1 URL (Links) /-/media/shared/documents/7/rd-investor-briefing-2017.pdf?la=fr-fr&hash=494FDD9185B1042615BEEBFB38FFDCB1D72C821B
www.cslbehring.ch
Datum der Indexierung 05.05.2021 04:36:59
Textauszug aus Quelle
MetaInfo: Text: R&D Investor Briefing 2017 December 5, 2017 R&D Investor Briefing Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include forward looking statements about CSL Limited and its related bodies corporate (CSL) financial results and estimates, business p
mehr Text anzeigen: >>
Title (HTML) 2017:8,15 494fdd9185b1042615beebfb38ffdcb1d72c821b:14,16,36 7:4,17 briefing:7,18 ch:19 cslbehring:20 documents:3,21 fr:11,12,22,33,34 fr fr:32 hash:13,23,35 investor:6,24 la:10,25,31 media:1,26 pdf:9,27,30 rd:5,28 shared:2,29
HTML Description pdf?la=fr-fr&hash=494FDD9185B1042615BEEBFB38FFDCB1D72C821B
Kombination Keywords phase other | with december | transplant donor | anti number | cidp vegf | products early | medicines enter | breakthrough disease | patients graft | specialty therapy | immunoglobulins fluad | haemophilia multimer | development aegis | global launch | hizentra safety | research antibody | study from | clinical renal | market need | portfolio commercial | privigen high | patient briefing | investor haegarda | japan product | afluria unmet |
erkannte Namen 7 Gérard Jenni | Alex Gertsch | Georg Ptak | Bill Mezzanotte | Jérôme Gremaud | Burkhard Statutory | Corona Anderer |
Anzahl Subdomain 2
Subdomain:
Log Metriken 1
outgoing (external) Links 0
Keywords in URL | briefing| documents| fr| hash| investor| la| media| pdf| rd| shared
alle ausgehende (outbound) Domain in www.cslbehring.ch
alle eingehende (inbound) Domain in www.cslbehring.ch
Textauszug aus Quelle
MetaInfo: Text: R&D Investor Briefing 2017 December 5, 2017 R&D Investor Briefing Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include forward looking statements about CSL Limited and its related bodies corporate (CSL) financial results and estimates, business p
mehr Text anzeigen: >>
Title (HTML) 2017:8,15 494fdd9185b1042615beebfb38ffdcb1d72c821b:14,16,36 7:4,17 briefing:7,18 ch:19 cslbehring:20 documents:3,21 fr:11,12,22,33,34 fr fr:32 hash:13,23,35 investor:6,24 la:10,25,31 media:1,26 pdf:9,27,30 rd:5,28 shared:2,29
HTML Description pdf?la=fr-fr&hash=494FDD9185B1042615BEEBFB38FFDCB1D72C821B
Kombination Keywords phase other | with december | transplant donor | anti number | cidp vegf | products early | medicines enter | breakthrough disease | patients graft | specialty therapy | immunoglobulins fluad | haemophilia multimer | development aegis | global launch | hizentra safety | research antibody | study from | clinical renal | market need | portfolio commercial | privigen high | patient briefing | investor haegarda | japan product | afluria unmet |
erkannte Namen 7 Gérard Jenni | Alex Gertsch | Georg Ptak | Bill Mezzanotte | Jérôme Gremaud | Burkhard Statutory | Corona Anderer |
Anzahl Subdomain 2
Subdomain:
Log Metriken 1
outgoing (external) Links 0
Keywords in URL | briefing| documents| fr| hash| investor| la| media| pdf| rd| shared
alle ausgehende (outbound) Domain in www.cslbehring.ch
alle eingehende (inbound) Domain in www.cslbehring.ch